ArticlePharmaceuticals (Basel, Switzerland)2025

Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study.

Noelia Pérez-Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.